ERYTECH announces management change Post author:admERY Post published:January 8, 2015 Post category:Newsroom ERYTECH today announced that Pierre-Olivier Goineau will be leaving the company to pursue other interests. You Might Also Like ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016 ERYTECH announces enrollment of first patient in Phase II study of eryaspase in pancreatic cancer July 28, 2014 ERYTECH to Present at the 2021 BIO CEO & Investor Conference February 10, 2021
ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer September 26, 2016
ERYTECH announces enrollment of first patient in Phase II study of eryaspase in pancreatic cancer July 28, 2014
